The following articles are presented as support for the
possible use of ionic minerals as a dietary supplement and nutritional supplement for
natural therapy. You will find more on fibromyalgia
here. You can also purchase this diet supplement disease treatment package below.
FIBROMYALGIA SYNDROME
Magazine: British Medical Journal; February 11, 1995
Section: Education & Debate
ABC of Rheumatology
Fibromyalgia is common in hospital practice. It is rarely
reported in children, and most patients are in their 40s or 50s. In all settings there is
a strong female preponderance (about 90%). It is well reported in the United States,
Canada, and Europe, but racial and social predisposition have not been adequately
addressed.
Symptoms are variable. Pain and fatiguability are usually prominent and
associated with considerable disability and handicap. Although patients can usually dress
and wash independently, they cannot cope with a job or ordinary household activities. Pain
is predominently axial and diffuse but can affect any region and may at times be felt all
over. Characteristically, analgesics, non-steroidal anti-inflammatory drugs, and local
physical treatments are ineffective and may even worsen symptoms.
Patients often have a poor sleep pattern with considerable latency and
frequent arousal. Typically they awake exhausted and feel more tired in the morning than
later in the day. Unexplained headache, urinary frequency, and abdominal symptoms are
common and may have been extensively investigated with no cause found. Patients usually
score highly on measures of anxiety and depression.
Although the term fibromyalgia syndrome is not
ideal, it does not imply causation and describes the commonest symptom. Idiopathic diffuse
pain syndrome, generalised rheumatism, and non-restorative sleep disorder are terms that
are increasingly preferred by some.
Clinical signs
Clinical findings are unremarkable, and the principal positive sign is the
presence of multiple hyperalgesic tender sites. In normal subjects these tender sites are
uncomfortable to firm pressure, but in patients with fibromyalgia
similar pressure produces a wince or withdrawal response. The degree of pressure is
clearly important; delivery of standard pressure with a spring device (dolorimeter) is
ideal, but reasonable palpation suffices for clinical purposes.
Hyperalgesia at one or two sites in the same quadrant often results from
periarticular lesions or referred tenderness from an axial structure. In fibromyalgia,
however, hyperalgesia is widespread and symmetrical. The number of tender sites required
by different diagnostic criteria varies, but eight or more are sufficient for clinical
purposes. Importantly, hyperalgesia is absent at sites that are normally non-tender. If a
patient claims to be tender all over, fabrication or psychiatric disturbance (psychogenic
rheumatism) is more likely. Osteoarthritis and periarticular syndromes are common and may
be present as incidental findings or as a trigger for the syndrome.
Differential diagnosis
Other conditions that may present with widespread pain, weakness, or
fatigue should be excluded by a limited investigational screen. Further tests may be
warranted if a patient's history and examination suggest a predisposing or coexistent
condition. Undertaking all investigations together reinforces the patient's confidence in
the accuracy of the diagnosis and is preferable to a drawn out sequence of tests. Fibromyalgia
may superimpose on pre-existing painful conditions such as osteoarthritis or cancer but
usually affects subjects with no other diagnosis (primary fibromyalgia).
Nature of fibromyalgia
The pathogenesis of the syndrome remains unclear. Clinical heterogeneity
is pronounced, and multiple factors are likely to relate to its development and
chronicity. Depending on the predominant symptom, fibromyalgia
may be categorised under various diagnostic labels. These conditions overlap and probably
represent different expressions in a spectrum of abnormality. Medicine has a traditional
bias towards a pathological explanation of disease, but with fibromyalgia
there is no investigational evidence of overt inflammatory, metabolic, or structural
abnormality and the problem appears functional rather than pathological.
Sleep disturbance
A strong association with sleep disturbance is suggested by:
· An increased frequency of non-restorative sleep
· Electroencephalographic evidence of reduced deep
non-rapid eye movement (non-REM) sleep with interruption by a waves (a-d intrusion)
· Reproduction of fibromyalgia
symptoms and hyperalgesic tender sites in normal subjects by selective deprivation of
non-REM (but not REM) sleep.
Chronic non-restorative sleep f8 has been suggested as a possible cause.
Various factors (such as regional pain syndrome, bereavement, and anxiety) cause reduced
deep sleep, with resultant somatic symptoms and fatigue. Once reduced sleep has been
established, reduced activity, declining aerobic fitness, and pain encourage perpetuation
of this aberrant sleep pattern.
Other possible causes
Deficiency of serotonin (or its precursor tryptophan) and other
abnormalities of the neuroendocrine axis have been proposed as mechanisms to explain both
the sleep disorder and pain associated with fibromyalgia.
Whether these reported abnormalities are cause or effect remains uncertain.
Vital aetiology has been proposed for patients with some forms of chronic
fatigue syndrome, but evidence for triggering viral infections in most patients with fibromyalgia
is lacking.
Affective symptoms are common, though whether they are primary or
secondary remains unclear. In fibromyalgia the predominance of
locomotor pain, presence of multiple hyperalgesic tender sites, development after
selective sleep deprivation, and different response to treatment argue for differentiation
from anxiety or depression with somatisation.
Management
There is no specific treatment for this condition, but individual patients
may be considerably helped. The single most important intervention is a comprehensible
explanation. Most patients expect a pessimistic cause for their devastating symptoms, and
they should be reassured that the pain does not reflect cancer, inflammation, or
structural damage. An explanation based on poor sleep and reduced fitness is readily
understood and helps patients to rationalise their symptoms, disability, and treatments.
It is helpful to include family members. Inquiry about life events may reveal problems
that merit open discussion and counselling. Patients with sublimated anxiety are more
likely to improve if their anxiety is identified and successfully addressed.
Controlled trials have confirmed the usefulness of low dose amitdptyline
or dothiepin (25-75 mg at night) and a graded exercise programme to increase aerobic
fitness.
Amitriptyline--The dose used is lower than that for depression. Its
efficacy may be due to its normalising effects on the sleep centre or pain gating at the
spinal cord level. Interestingly, cyclobenzaprine (a tricyclic muscle relaxant with no
antidepressant action) is also effective. If these drugs are ineffective after a trial of
four to six weeks, further drug treatment should be avoided. Benzodiazepines and other
hypnotics have no place in treatment.
Increasing aerobic exercise is intended to improve sleep and restore
fitness. It may initially exacerbate symptoms, but patients should be encouraged to
continue despite pain (the opposite advice to that for someone with synovitis or joint
damage). An important element is that the locus of control is now within the patient--it
is up to them, not doctors or drugs, to improve their situation.
Operant and other illness behaviour is common. This needs to be recognised
and eliminated by educating family members.
Coping strategies (such as meditational yoga) may permit patients to
better control the extent to which pain and fatigue intervene in their life.
Prognosis
The prognosis for fibromyalgia is poor. In one
British study less than one in 10 patients diagnosed in hospital lost their symptoms over
five years. Nevertheless, suitable advice can help most patients to learn to cope better
with their condition and, importantly, to avoid further unnecessary investigations and
drug treatments.
Principal clinical findings
· Discordance between symptoms and disability and
objective findings
· No objective weakness, synovitis, or neurological
abnormality
· Multiple hyperalgesic tender sites {axial and upper
and lower limbs)
· Pronounced tenderness to rolling of skin fold
(mid-trapezius)
· Cutaneous hyperaemia after palpation of tender sites
or rolling of skin fold
· Negative control (non-tender) sites (such as forehead,
distal forearm, and lateral fibular head)
Common hyperalgesic tender sites
· Low cervical spine (C4-C6 interspinous ligaments)
· Low lumbar spine (L4-S1 interspinous ligaments)
· Suboccipital muscle (posterior base of skull) *
Mid-supraspinatus
· Mid-point of upper trapezius
· Pectoralis insertion--maximal lateral to second
costochondral junction
· Lateral epicondyle--tennis elbow sites, 1-2 cm distal
to epicondyle
· Gluteus medius--upper, outer quadrant of buttock
· Greater trochanter
· Medial fat pad of knee
Differential diagnosis and investigations